Back to Search
DAVID HOCHHAUSER, MD
MD
Emergency Medicine Physician
NPI: 1255317368IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MD2009-0733(NM)MD419703(PA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 1984
Research & Publications (20)
Primary tumour resection and survival in the palliative management of metastatic colorectal cancer.
PMID 18644695·Eur J Surg Oncol·2009
4-observational
Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors.
PMID 19276288·Clin Cancer Res·2009
3-trial
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
PMID 18577995·Br J Cancer·2008
8-other
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
PMID 18483319·Mol Cancer Ther·2008
7-preclinical
The role of 99mTc-depreotide in the management of neuroendocrine tumours.
PMID 18391727·Nucl Med Commun·2008
8-other
Targeting the inverted CCAAT Box-2 of the topoisomerase IIalpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimer.
PMID 17977733·Bioorg Med Chem·2008
7-preclinical
A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
PMID 17517500·Clin Oncol (R Coll Radiol)·2007
4-observational
Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
PMID 17237293·Mol Cancer Ther·2007
7-preclinical
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment.
PMID 16505093·Mol Cancer Ther·2006
7-preclinical
Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cells.
PMID 17011187·Bioorg Med Chem Lett·2006
7-preclinical
Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoter.
PMID 16991167·Chembiochem·2006
8-other
Epidermal growth factor receptor expression and activation in neuroendocrine tumours.
PMID 16629834·J Neuroendocrinol·2006
4-observational
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents.
PMID 16010413·Int J Oncol·2005
8-other
Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multidrug resistant (MDR1) gene.
PMID 16254941·Chembiochem·2005
8-other
Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?
PMID 15756436·Oncol Rep·2005
8-other
Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).
PMID 15475435·Clin Cancer Res·2004
8-other
Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
PMID 15379563·Biochemistry·2004
8-other
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
PMID 15374986·Cancer Res·2004
7-preclinical
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum.
PMID 15231247·Lancet Oncol·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 211 N 12TH ST
LEHIGHTON, PA 18235 - Phone
- (610) 377-7080
Quick Facts
- NPI
- 1255317368
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile